Literature DB >> 17158748

The histone variant mH2A1.1 interferes with transcription by down-regulating PARP-1 enzymatic activity.

Khalid Ouararhni1, Réda Hadj-Slimane, Slimane Ait-Si-Ali, Philippe Robin, Flore Mietton, Annick Harel-Bellan, Stefan Dimitrov, Ali Hamiche.   

Abstract

The histone variant mH2A is believed to be involved in transcriptional repression, but how it exerts its function remains elusive. By using chromatin immunoprecipitation and tandem affinity immunopurification of the mH2A1.1 nucleosome complex, we identified numerous genes with promoters containing mH2A1.1 nucleosomes. In particular, the promoters of the inducible Hsp70.1 and Hsp70.2 genes, but not that of the constitutively expressed Hsp70.8, were highly enriched in mH2A1.1. PARP-1 was identified as a part of the mH2A1.1 nucleosome complex and was found to be associated with the Hsp70.1 promoter. A specific interaction between mH2A1.1 and PARP-1 was demonstrated and found to be associated with inactivation of PARP-1 enzymatic activity. Heat shock released both mH2A1.1 and PARP-1 from the Hsp70.1 promoter and activated PARP-1 automodification activity. The data we present point to a novel mechanism for control of Hsp70.1 gene transcription. mH2A1.1 recruits PARP-1 to the promoter, thereby inactivating it. Upon heat shock, the Hsp70.1 promoter-bound PARP-1 is released to activate transcription through ADP-ribosylation of other Hsp70.1 promoter-bound proteins.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17158748      PMCID: PMC1686608          DOI: 10.1101/gad.396106

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  38 in total

1.  Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter.

Authors:  R Ferreira; I Naguibneva; M Mathieu; S Ait-Si-Ali; P Robin; L L Pritchard; A Harel-Bellan
Journal:  EMBO Rep       Date:  2001-08-23       Impact factor: 8.807

2.  Histone H2A variants and the inactive X chromosome: identification of a second macroH2A variant.

Authors:  B P Chadwick; H F Willard
Journal:  Hum Mol Genet       Date:  2001-05-01       Impact factor: 6.150

3.  The histone variant macroH2A interferes with transcription factor binding and SWI/SNF nucleosome remodeling.

Authors:  Dimitar Angelov; Annie Molla; Pierre-Yves Perche; Fabienne Hans; Jacques Côté; Saadi Khochbin; Philippe Bouvet; Stefan Dimitrov
Journal:  Mol Cell       Date:  2003-04       Impact factor: 17.970

4.  Immunoaffinity purification of mammalian protein complexes.

Authors:  Yoshihiro Nakatani; Vasily Ogryzko
Journal:  Methods Enzymol       Date:  2003       Impact factor: 1.600

5.  The crystal structure of AF1521 a protein from Archaeoglobus fulgidus with homology to the non-histone domain of macroH2A.

Authors:  Mark D Allen; Ashley M Buckle; Suzanne C Cordell; Jan Löwe; Mark Bycroft
Journal:  J Mol Biol       Date:  2003-07-11       Impact factor: 5.469

Review 6.  Inactivating chromosomes: a macro domain that minimizes transcription.

Authors:  Andreas G Ladurner
Journal:  Mol Cell       Date:  2003-07       Impact factor: 17.970

Review 7.  Phylogenomics of the nucleosome.

Authors:  Harmit S Malik; Steven Henikoff
Journal:  Nat Struct Biol       Date:  2003-11

Review 8.  The PARP superfamily.

Authors:  Jean-Christophe Amé; Catherine Spenlehauer; Gilbert de Murcia
Journal:  Bioessays       Date:  2004-08       Impact factor: 4.345

Review 9.  PARP goes transcription.

Authors:  W Lee Kraus; John T Lis
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Chromatin loosening by poly(ADP)-ribose polymerase (PARP) at Drosophila puff loci.

Authors:  Alexei Tulin; Allan Spradling
Journal:  Science       Date:  2003-01-24       Impact factor: 47.728

View more
  94 in total

Review 1.  Histone variants in metazoan development.

Authors:  Laura A Banaszynski; C David Allis; Peter W Lewis
Journal:  Dev Cell       Date:  2010-11-16       Impact factor: 12.270

2.  The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3.

Authors:  Pascal Drané; Khalid Ouararhni; Arnaud Depaux; Muhammad Shuaib; Ali Hamiche
Journal:  Genes Dev       Date:  2010-05-26       Impact factor: 11.361

Review 3.  Control of tumorigenesis and chemoresistance by the DEK oncogene.

Authors:  Erica Riveiro-Falkenbach; María S Soengas
Journal:  Clin Cancer Res       Date:  2010-05-25       Impact factor: 12.531

4.  Poly(ADP-ribose) polymerase-1 (PARP-1) contributes to the barrier function of a vertebrate chromatin insulator.

Authors:  Mari Aker; Karol Bomsztyk; David W Emery
Journal:  J Biol Chem       Date:  2010-09-27       Impact factor: 5.157

Review 5.  Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review.

Authors:  Rosalba Camicia; Hans C Winkler; Paul O Hassa
Journal:  Mol Cancer       Date:  2015-12-11       Impact factor: 27.401

6.  The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing.

Authors:  Matthew J Gamble; Kristine M Frizzell; Christine Yang; Raga Krishnakumar; W Lee Kraus
Journal:  Genes Dev       Date:  2009-12-15       Impact factor: 11.361

7.  The histone variant macroH2A1.1 is recruited to DSBs through a mechanism involving PARP1.

Authors:  Chang Xu; Ye Xu; Ozge Gursoy-Yuzugullu; Brendan D Price
Journal:  FEBS Lett       Date:  2012-09-29       Impact factor: 4.124

Review 8.  Molecular mechanisms driving transcriptional stress responses.

Authors:  Anniina Vihervaara; Fabiana M Duarte; John T Lis
Journal:  Nat Rev Genet       Date:  2018-06       Impact factor: 53.242

Review 9.  Transcriptional control by PARP-1: chromatin modulation, enhancer-binding, coregulation, and insulation.

Authors:  W Lee Kraus
Journal:  Curr Opin Cell Biol       Date:  2008-04-29       Impact factor: 8.382

10.  PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells.

Authors:  Sung Hoon Cho; Shreevrat Goenka; Tiina Henttinen; Prathyusha Gudapati; Arja Reinikainen; Christine M Eischen; Riitta Lahesmaa; Mark Boothby
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.